Lipid-driven immunometabolic responses in atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Immunology
• Metabolic Disease

Background:

• Atherosclerosis is a chronic inflammatory condition characterized by lipoprotein accumulation in arteries.
• Current therapies inadequately prevent most cardiovascular events, highlighting the need for novel treatments.

Purpose of the Study:

• To review novel mechanistic insights into lipid-driven immune activation in atherosclerosis.
• To explore how immunometabolic interactions contribute to disease pathogenesis.
• To identify potential new anti-inflammatory therapeutic targets.

Main Methods:

• Review of current literature on atherosclerosis, lipid metabolism, and immune cell function.
• Analysis of molecular mechanisms linking lipoproteins to immune cell activation.
• Examination of immunometabolic crosstalk within atherosclerotic plaques and the liver.

Main Results:

• Lipoprotein-derived components, including cholesterol crystals and apolipoprotein B-peptides, activate macrophages and T cells.
• Lipoproteins modulate regulatory T cells, influencing vascular inflammation.
• T cells impact hepatic inflammation and lipoprotein metabolism, indicating complex immune-metabolic crosstalk.

Conclusions:

• Lipid-driven immune responses are central to atherosclerosis pathogenesis.
• Targeting these immunometabolic pathways may lead to effective anti-atherosclerotic therapies.
• Further research into the intricate interplay between lipids and immunity is crucial for clinical advancement.